(S)-(-)-2-Methyl-1-butanol
Common Name: |
(S)-(-)-2-Methyl-1-butanol |
IUPAC Name: |
(2S)-2-methylbutan-1-ol |
Molecular Formula: |
C3H5NaO2 |
SMILES: |
CCC(C)CO |
Inchi: |
1S/C5H12O/c1-3-5(2)4-6/h5-6H,3-4H2,1-2H3/t5-/m0/s1 |
Inchi Key: |
QPRQEDXDYOZYLA-YFKPBYRVSA-N |
Cas No: |
1565-80-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
4 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
96.06 |
Mass (g/mol) |
88.089 |
Molar Refractivity |
16.36 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
|
TPSA |
40.13 |
Hetero Atoms |
1 |
Heavy Atoms |
6 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
128.00 to 129.00 |
Vapor Pressure (mmHg@25.00 °C) |
4.76 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.67 |
LogP |
1.025 |
iLOGP |
-7.68 |
XLOGP3 |
0.33 |
WLOGP |
-0.85 |
MLOGP |
0.03 |
ESOL Log S |
-0.58 |
ESOL Solubility (mg/ml) |
25.4 |
ESOL Solubility (mol/l) |
0.265 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.74 |
Ali Solubility (mg/ml) |
17.6 |
Ali Solubility (mol/l) |
0.18 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
0.09 |
Silicos-IT Solubility (mg/ml) |
118 |
Silicos-IT Solubility (mol/l) |
1.22 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-6.65 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.429 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.99 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |